Trials / Completed
CompletedNCT02804867
Spot Depression Study
A Blood Test to Identify Persons at Risk of Developing Depression or Bipolar Disorder
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- University of Cambridge · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study aims to identify signs of depression and bipolar disorder by measuring changes of certain molecules (biomarkers) that can be detected in dried blood spots. Our goal is to use these biomarkers to develop a diagnostic test to enable early treatment, which can lead to better patient outcomes.
Detailed description
Bipolar disorder and major depression are serious mental health conditions that have a devastating impact on patients, their families and friends, and society. Currently, no laboratory test exists for these disorders. We are trying to develop a molecular test based on blood spots (small spots of blood obtained from patients' fingertips that have been dried on special paper). Volunteers take part by filling out the questionnaire at www.spot-depression.org. They may then be selected to provide a dried blood spot, which can be collected at home using a kit that will be mailed to their address.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Online questionnaire and self-administered blood spot |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2016-06-17
- Last updated
- 2017-02-23
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02804867. Inclusion in this directory is not an endorsement.